Case 3 – Alan Hays Consultation 1 Doctor :

Slides:



Advertisements
Similar presentations
Chronic kidney disease
Advertisements

Chronic kidney disease
Proteinuria and Haematuria – an update Alex Heaton
CKD ML/LH What are people hoping to cover from the session today?
The Role of Urine cytology in the investigation of Haematuria? B Barrass Audit Meeting 17 th May 2006.
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
Nephrotic/nephritic syndrome
RENAL DISEASE – A GENERAL PRACTICE PERSPECTIVE Dr Shareen Hallas.
Urinary tract infections … I can’t wait…. Symptoms of UTI: Dysuria, frequency, urgency, suprapubic tenderness, haematuria, polyuria.
SAIMA USMAN. HAEMATURIA Common finding Incidental DEFINING HAEMATURIA Visible haematuria Non visible haematuria (dipstick and microscopic)
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
Ken Chow. What is haematuria?  Macroscopic Visible haematuria Pink or red  Microscopic Gold standard – Microscopy ○ Presence of >3 RBCs per high-powered.
Chronic Kidney Disease NICE Guidelines 2008 Dr Jennifer Kuo Dr Naeema Rashid Dr Shamita Das.
Asymptomatic bacteriuria in the elderly Dr Grace Sluga Consultant Microbiologist.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Case Presentation Dr Mohan Shenoy Consultant Paediatric Nephrologist Royal Manchester Children’s Hospital.
Chronic Kidney Disease Jacqueline Annand – CKD Nurse Mary Simpson – CKD Nurse Joyce Mackie – Pre Dialysis/Transplant liaison Sister.
Lesley Stevens MD Tufts-New England Medical Center
The laboratory investigation of urinary tract infections
Hematuria. CONTINUITY CLINIC Objectives Plan the appropriate management of a child with microscopic hematuria Plan the appropriate management of a child.
Hematuria By: Kayla Jahr.
Red Urine – a mystery Shaila Sukthankar.
Everything you wanted to know about CKD SUE GILDERSLEVE RENAL NURSE SPECISLIST.
Diabetic Nephropathy Case Presentations. UA (Urine Dipstick) Use as an initial screen for all patients Negative to trace proteinuria requires further.
Proteinuria DR Badi AlEnazi Consultant pediatric endocrinology and diabetologest.
Dysuria and Frequency Dysuria: difficult and painful passage of urine. Frequency: repetetive voiding of relatively small amounts of urine.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
J Winterbottom 2005 Chronic Renal Failure Jean Winterbottom Clinical Educator MRI.
HEMATURIA Danger Signal that can’t be ignored. 1. Duration of symptoms and are they painful? 2.Presence of symptoms of an irritated bladder 3.What portion.
Heamaturia Dr.Badi AlEnazi Consultant pediatric endocrinologest and diabetologest.
Red urine Hemoglobinuria Myoglobinuria Drugs (rifampicin),food
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Imaging in Haematuria Dr. Jaswinder Singh Consultant Radiologist
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Urinary Tract System Bladder Cancer.
Cancer - renal pelvis or ureter. Overview Cancer of the renal pelvis or ureter is cancer that forms in the pelvis or the tube that carries urine from.
Paediatrics 4 Microteaching: Haematuria in children Zara Gall Victoria Hopkinson Shahid Islam (Previous presentation by Satish Maddenini and Lynsey McHugh)
Microscopic Haematuria. Transient Causes Transient –UTI –Exercise Spurious –Menstrual contamination –Sexual intercourse.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Interstitial Cystitis
Hematuria Resident Lecture
HEMATURIA DAVID SPELLBERG M.D.,FACS NAPLES UROLOGY ASSOCIATES.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
OPD follow up 1. General P/E Blood pressure Sites of insulin injection Deep tendon reflex 2.
Case 3 75 Yr male. pT1 TCC upper ureter. Smoker CKD stage 2 Diabetic Monday morning. Patient admitted for lap nephroureterectomy. Discuss procedure and.
Kidney Disease Healthy Christian Presentation May 25, 2016.
UTI NICE guidance. UTI Previous heavy burden of investigation, prophylaxis and follow up. The aim of this guideline is to achieve more consistent clinical.
CSCCN Central South Coast Cancer Network Southampton & West Charlie Besley Northeast Charlotte Hutchings Portsmouth & Southeastern Meryl Deane Isle of.
OAB / LUTS Urology Pathway for Primary Care within Frimley Health locality Developed with key local stakeholders including Urologists, Gynaecologists,
A. Evaluation point Hospitalization (10 or more days)
Section 6: Management in primary care
The LIVES Sub-analysis
Haematuria Haematuria is a common condition and one which must be taken seriously. Haernaturia is usually divided into :- - Macroscopic (where the urine.
Management of Urinary Tract Infections Renal Block
Management of Urinary Tract Infections Renal Block
Women Over 16 Years at Presentation
Haematuria Dr. Abdelmoniem E. Eltraifi College of Medicine & KKUH
Recurrent UTI in young women
Hypertension evaluation
Section 5: Configuration of healthcare to manage CKD
Evaluation of Proteinuria
DR JOSH CULLIMORE GP CLINICAL LEAD UROLOGY
Urological malignancies
Approach to red urine in children
HAEMATURIA (Whistle-stop tour)
Presentation transcript:

Case 3 – Alan Hays Consultation 1 Doctor : You have not seen 38 yr old Alan Hays, a roofer, before, as he is a new patient. The nurse picked up microscopic haematuria at his new patient medical and asked him to come in to discuss this with you.

Case 3 – Alan Hays Consultation 1 Patient : You are Alan Hays, aged 38, a roofer. You moved house recently, and joined the practice, at your new pt medical the nurse found blood in your urine, and asked you to book in with the doctor. You are fit and well, completely asymptomatic. You live with your 35 yr old girlfriend, Donna. You have taken up running with a couple of mates to try to get fitter. You smoke 10/day and drink 15 pints beer per wk.

Microscopic/ Invisible haematuria Visible haematuria (VH) = macroscopic haematuria/ gross haematuria Invisible haematuria (IH) = microscopic haematuria or ‘dipstick positive haematuria’ Significant haematuria is defined as: any single episode of VH any single episode of symptomatic NVH (in absence of UTI or other transient causes). persistent asymptomatic -IH (in absence of UTI or other transient causes) : defined as 2 out of 3 dipsticks positive (≥1+, not trace) for IH

Microscopic/ Invisible Haematuria – what it isn’t Transient microscopic haematuria: UTI Exercise related (repeat ≥ 3d after exercise) Spurious microscopic haematuria: Menstrual contamination Sexual intercourse Foods (esp. beetroot, blackberries and rhubarb) Rhabdomyolysis Drugs (doxorubicin, chloroquine, rifampicin) Chronic lead or mercury poisoning.

Case 3 – Alan Hays Consultation 2 Doctor: Alan has come back to see you to discuss a second urine test, which shows 1 + blood only. He has just been on holiday for a week to Tenerife, where he had a good rest. He feels great, but is a bit anxious now about his test result.

Case 3 – Alan Hays Consultation 2 – patient: You were asked to bring in a further urine sample 1 wk later, and the receptionist called to ask you to book in with the doctor again to discuss the result. If asked to be examined your BP is 122/73

How risky is it? 2 – 13% of the population may have IH but < 1.5% of these have significant pathology. Urine dipstick testing is highly sensitive (97%) and moderately specific (75%) for the detection of haematuria Visible haematuria is associated with cancer in 8-25% of cases, IH assoc with cancer in only 2.6% < 0.5% of people aged under 50 years investigated for asymptomatic invisible haematuria have cancer Data suggest that invisible haematuria detected on dipstick screening has a sensitivity of < 3% and a positive predictive value of 0.2% for cancer Invisible haematuria =20 times more likely to develop end stage renal failure than those without: but the absolute risk is low: 34 v 2/100 000 person years!

Testing Presence of haematuria (VH or IH) should not be attributed to anti-coagulant or anti-platelet therapy and patients should be evaluated regardless of these medications. Population screening is considered justified in Japan but no other country has a national programme Regard two out of three positive dipstick tests as confirmation 1+ or more NOT trace

Assessment SYMPTOMS: Also ascertain Examine visible haematuria, loin pain, Dysuria Pelvic pain Also ascertain Risk factors for urinary tract cancer (smoking; exposure to chemicals used in leather, dye, and rubber manufacturing; cyclophosphamide treatment). A family history (Alports, Polycystic kidneys) Examine Blood pressure Abdominally

UTI Exclude UTI and/or other transient cause If UTI then treat and test again after proof of clearance – 2 out of 3 positive means IH Remember recurrent UTI can be a sx of bladder cancer or in men 35-50 with sx. chronic prostatitis Check urine for blood again in a week or more

Tests Plasma creatinine/eGFR. Measure Proteinuria: Send urine for albumin:creatinine ratio (ACR) on a random sample (according to local practice). Sickle cell disease/ trait (Urothelial cancers are detected by cystoscopy rather than imaging, imaging alone can provide false reassurance and should not be undertaken) (N.B. 24 hour urine collections for protein are rarely required. An approximation to the 24 hour urine protein or albumin excretion (in mg) is obtained by multiplying the ratio (in mg/mmol) x10.)

Management 1 3 possible routes: Urology Referral Nephrology referral So if after all the above there is no UTI, 2 out of 3 positive dipstick test, normal clinical examination and normal/ stable eGFR then: 3 possible routes: Urology Referral Nephrology referral Continued Observation

Cystoscopy and imaging of upper renal tract – CT  USS X Urological referral All patients with a-IH aged ≥ 35-40 yrs or even younger if smokers/ other risk factors for bladder cancer NICE says urgent if >60 yrs (Asymptomatic visible haematuria (any age)).* (Sustained symptomatic IH (any age)). Cystoscopy and imaging of upper renal tract – CT  USS X There is no high quality evidence that asymptomatic IH for urinary tract cancer improves outcome compared with investigating visible haematuria only. IH becomes VH in 3 months of bladder cancer recurrences * N.B. Some patients <40 yrs with cola-coloured urine and an inter-current (usually upper respiratory tract) infection will have an acute glomerulonephritis, and a nephrology referral may be considered more appropriate if clinically suspected.

Nephrological referral 1)Any Age: eGFR < 30 mL/min/1.73m (CKD 4 and5) A sustained > or = 25% ↘ in eGFR and a change in category or a sustained ↘of ≥15 mL/min/1.73m2 2) Under 40: Urinary ACRof ≥30 mg/mmol (2 measurements) BP > 140/90 eGFR < 60 Visible haematuria coinciding with intercurrent (usually upper respiratory tract) infection Concern about rare or genetic causes of haematuria

Nephrology referral risks and benefits: Benefits of interventions to slow progression of kidney disease (BP control, Salt restriction, RAS blockade to reduce proteinuria) do not vary with renal histology Most conditions diagnosed by renal biopsy in patients with a-IH (IgA and thin BM nephropathy) are not amenable to disease specific treatment; even membranous nephropathy treatment only benefits those with proteinuria or a progressive reduction in renal function

Nephrology referral Kidney biopsy provides a tissue diagnosis but carries important risks, including life threatening bleeding NB Hypertension is a common unrelated comorbidity in older patients

Observation in Primary Care Most patients with IH wont meet the referral criteria Monitoring for as long as the haematuria persists Consider USS of renal tract if not referring and >CKD3 Most are likely to have glomerular haematuria (IgA disease and thin basement membrane nephropathy) Annual assessment of blood pressure Dipstick test of urine for IH estimated glomerular filtration rate urinary ACR The 1% risk of missed urological cancer in patients already investigated once for asymptomatic invisible haematuria does not justify repeat urological testing

https://www.nice.org.uk/guidance/cg182/resources http://www.bmj.com/content/349/bmj.g6768